40 results about "Dietary interventions" patented technology

This invention relates to an effective dietary intervention plan. In one aspect all food is withheld for a period of at least 5 days, except for tropical root crops. In another aspect the invention relates to the treatment of various symptoms, conditions or diseases such as Diarrhea, constipation, congestion, eczema, asthma, fatigue, muscle weakness, tension, and spasms, irritable bowel syndrome, swelling, anxiety, multiple chemical sensitivities, moderate to extensive and moderate to severe symptoms due to food allergies, sensitivities, and intolerances, bloating, pain, headaches, leaky gut, hyperactivity, sleeping difficulties, severe underweight, eating disorders, obsessive, compulsive disorders, panic attacks, sensory sensitivities, Alzheimer's disease, acid reflux, irritability, delayed motor skills, delayed social skills, autism, PDD, infantile spasms, seizures by withholding from the patient for a period of at least 5 days all food except for concentrated forms of concentrated tropical root crops. Preferably the patient is also removed from external environmental sources of allergens. After the initial withholding period new foods may be introduced according to a particular selection and schedule. In another aspect of the invention the subject undergoes an effective dietary intervention plan in which at least five (5) tropical root crops are selected, each eaten on a successive day, along with selected other meat, vegetables, and oils that the subject has never eaten before, eating a different selection of meat, vegetables, and oils each from different food families each day, with no food or food family being repeated for at least 5 days. In another aspect the invention relates to the treatment of various symptoms, conditions or diseases such as Diarrhea, constipation, congestion, eczema, asthma, fatigue, muscle weakness, tension, and spasms, irritable bowel syndrome, swelling, anxiety, multiple chemical sensitivities, moderate to extensive and moderate to severe symptoms due to food allergies, sensitivities, and intolerances, bloating, pain, headaches, leaky gut, hyperactivity, sleeping difficulties, severe underweight, eating disorders, obsessive, compulsive disorders, panic attacks, sensory sensitivities, Alzheimer's disease, acid reflux, irritability, delayed motor skills, delayed social skills, autism, PDD, infantile spasms, seizures by withholding from the patient for a period of at least 5 days all food except for concentrated forms of concentrated tropical root crops. Preferably the patient is also removed from external environmental sources of allergens. After the initial withholding period new foods may be introduced according to a particular selection and schedule. In another aspect of the invention the subject undergoes an effective dietary intervention plan in which at least seven (7) tropical root crops are selected, each eaten on a successive day, along with selected other meat, vegetables, and oils that the subject has never eaten before, eating a different selection of meat, vegetables, and oils each from different food families each day, with no food or food family being repeated for at least 7 days. In another aspect the invention relates to the treatment of various symptoms, conditions or diseases such as Diarrhea, constipation, congestion, eczema, asthma, fatigue, muscle weakness, tension, and spasms, irritable bowel syndrome, swelling, anxiety, multiple chemical sensitivities, moderate to extensive and moderate to severe symptoms due to food allergies, sensitivities, and intolerances, bloating, pain, headaches, leaky gut, hyperactivity, sleeping difficulties, severe underweight, eating disorders, obsessive, compulsive disorders, panic attacks, sensory sensitivities, Alzheimer's disease, acid reflux, irritability, delayed motor skills, delayed social skills, autism, PDD, infantile spasms, seizures by withholding from the patient for a period of at least 5 days all food except for concentrated forms of concentrated tropical root crops. Preferably the patient is also remo

The present invention discloses a preparation method of modified soybean dietary fiber powder with sugar and lipid-lowering effects, and the finished product is prepared by hydrolysis, neutralization, addition of oligosaccharides, emulsification, homogenization, flash evaporation sterilization, drying and sifting. After consumption of the product prepared by the method, the growth of beneficial bacteria in the body can be promoted, intestinal function is improved, and the modified soybean dietary fiber powder and soybean dietary fiber have dual sugar and lipid-lowering effects. The modified soybean dietary fiber powder is especially suitable for consumption of the elderly, constipation crowd, and sugar and lipid-lowering and slimming groups, can meet the needs of different groups, has the function of reducing blood sugar, blood lipid and blood pressure, preventing obesity, quickly replenishing physical energy for sub healthy groups, and increasing the body prebiotics (bacteria) and the like, and achieve the healthy purpose by dietary intervention and regulation.

The invention discloses a food and drink composition. The food and drink composition is prepared from the following components based on specific content combination: edible vegetable oil, medium chain triglyceride, hydrolyzed small molecular protein powder, dietary fiber powder, nut meat, egg powder, polyols, sodium caseinate, mono and di-glycerin fatty acid ester, docosahexaenoic acid, arachidonic acid, taurine, phosphatidylcholine, phosphatidylserine, mineral substances, vitamins and the like, all components are interacted, the food and drink composition can promote metabolism in the body to produce acetoacetic acid, beta-hydroxybutyrate and acetone through dietary intervention to cause a series of biochemical influences on the brain under a condition of meeting primary nutrients requirement for the growth of autistic children, so as to achieve the effect of intervention treatment of infantile autism. The invention also discloses a preparation method and application of the food and drink composition.

The present invention provides a method for assessing the presence or the risk of development of type 2 diabetes mellitus in a subject based on abundance data of several CAGs. Also provided is a method for evaluating efficacy of diet intervention or disease treatment in a subject having type 2 diabetes mellitus based on abundance data of these CAGs.

The invention discloses an application of soluble dietary fibers in kelp in preparation of a medicine and functional food for improving ulcerative colitis. According to the invention, soluble dietary fibers are extracted from the kelp residues, an ulcerative colitis mouse model is constructed, and it is verified for the first time that the soluble dietary fibers can inhibit weight loss and disease activity indexes of mice; inhibit colon disease and shortening degree; improve a level of oxidative stress in the colon; balance a level of inflammatory factors in a body; up-regulate expression of intestinal tight junction protein; restore diversity and abundance of intestinal flora; and increase production of short-chain fatty acids such as butyric acid, acetic acid, and propionic acid. The soluble dietary fibers in kelp belong to natural active substances, are safe and free of toxic and side effects, can be used for treating enteritis and other gastrointestinal diseases based on diet intervention, avoid adverse reactions of traditional drug treatment, and have good application prospects.

The present invention provides a diagnostic method which may be used to determine the likelihood that a subject with Irritable Bowel Syndrome (IBS) will respond to treatment with an IBS intervention diet or faecal microbiota transplant (FMT). In particular, the method may be used to predict, or determine the likelihood of, a positive response of the subject with IBS to treatment with an IBS intervention diet or FMT, especially to determine the likelihood that the dietary intervention or FMT may have a positive (i.e. beneficial) effect on the subject's Gl tract, specifically the Gl tract microbiota, or other symptoms or complications of IBS (e.g. reducing severity thereof). The method of the present invention is based on analysing the abundance of certain bacteria in Gl tract samples, e.g.by nucleic acid analysis.

The invention discloses a dietary composition for cancer dietary intervention and a preparation method thereof. The dietary composition comprises the following components in percentage by weight: 40-60% of tea pigment, 10-20% of an agaricus blazei murill extract, 8-12% of a grifola frondosa extract, 4-6% of a dandelion extract and 15-25% of a chlorella pyrenoidosa extract. The preparation method comprises the following steps: S1, preparing tea pigment powder for later use; S2, preparing the agaricus blazei murill extract powder for later use; S3, preparing the grifola frondosa extract powder for later use; S4, preparing dandelion extract powder for later use; S5, preparing the chlorella pyrenoidosa extract powder for standby application; and S6, uniformly mixing the tea pigment powder, theagaricus blazei murill extract powder, the grifola frondosa extract powder, the dandelion extract powder and the chlorella pyrenoidosa extract powder obtained in the steps S1, S2, S3, S4 and S5 in percentage by weight to obtain the dietary composition. The dietary composition disclosed by the invention has an excellent body conditioning effect.

The invention relates to a healthy diet intervention system and method for determining a diet structure of a user based on an image recognition technology. The method comprises the steps of: by adopting techniques by image recognition, identifying, metering and estimating, classifying and sequencing diet main material types of a user in a preset period, and synchronizing the personal health recordof the user, so that a healthy diet list recommended for the user is planned, the defect of inaccurate diet intervention caused by negligence or omission of related food due to adoption of a user memory mode is avoided, the defect that trouble is brought to the diet of the user due to the fact that the user needs to carry paper, a pen and a metering device in the mode that the user records the diet of each meal at regular time is overcome, image recognition of the diet of the user can be conducted through a simple mobile phone, and operation is simple and reliable.

The present invention relates to an in vitro testing platform for the study of metabolic liver disease and related therapeutic strategies, composed of an artificial spheroidal microtissue comprising at least hepatocytes and hepatic stellate cells, and at least one type of hepatic inflammatory cells and further medium and reagents capable to establish and simulate different stages of metabolic liver disease and their progression and testing preventive and therapeutic strategies by pharmacological and / or dietary interventions.

The invention discloses a dietary composition for cardiovascular and cerebrovascular disease dietary intervention, and a preparation method thereof. The dietary composition comprises 40-60 wt% of a tea pigment, 5-15 wt% of Radix Astragali extract, 5-15 wt% of Camellia chrysantha extract, 5-15 wt% of Codonopsis pilosula extract, 5-15 wt% of Hericium erinaceus extract and 5-15 wt% of hawthorn extract. The preparation method comprises the following steps: S1, preparing tea pigment powder for later use; S2, preparing Radix Astragali extract powder for later use; S3, preparing Camellia chrysantha extract powder for later use; S4, preparing Codonopsis pilosula extract powder for later use; S5, preparing Hericium erinaceus extract powder for later use; S6, preparing hawthorn extract powder for later use; and S7, uniformly mixing the powders obtained in steps S1, S2, S3, S4, S5 and S6 to obtain the dietary composition. The dietary composition has excellent preventing and conditioning effects on cardiovascular and cerebrovascular diseases.

The invention discloses a nursing system and method for patients with cardiovascular system diseases, and the system comprises the steps: obtaining first dietary guidance information in a first communication platform according to first disease information; obtaining a first dietary habit of a first user; constructing a first dietary control knowledge base according to the first dietary guidance information and the first dietary habit; generating a first dietary interaction model according to the first dietary control knowledge base and a first inference rule; obtaining first dietary image information according to a first camera; inputting the first dietary image information into the first dietary interaction model to obtain first output information; converting and outputting the first output information according to a first voice output device. The system solves the technical problem that in the prior art, cardiovascular disease patients are prone to being affected by various influence factors after being discharged, diet intervention cannot be accurately monitored, nursing after being discharged is not effective enough, and recovery effect of the patients is limited.

A method for predicting the degree of weight loss in male subject attainable by applying one or more dietary interventions to a subject, said method comprising determining the level of one or more biomarkers in one or more samples obtained from the subject, wherein the biomarkers are selected from sex hormone-binding globulin, beta-2-microglobulin and serum paraoxonase / arylesterase.

The present invention relates to a method for predicting the degree of weight loss attainable by applying one or more dietary interventions to a subject and / or the degree of maintenance of weight loss following one or more dietary interventions; which method comprises determining the level of microRNA-486 (miR-486) in one or more samples obtained from the subject; and / or determining the nucleotide of the subject at one or more polymorphic positions genetically linked to miR-486.

The present invention provides a method for predicting the degree of weight loss attainable by applying one or more dietary interventions to a subject, said method comprising a step of determining thelevel of one or more biomarkers in one or more samples obtained from the subject, wherein the one or more biomarkers include vitamin K-dependent protein C.

The invention discloses a food and drink composition. The food and drink composition is prepared from the following components based on specific content combination: edible vegetable oil, medium chain triglyceride, hydrolyzed small molecular protein powder, dietary fiber powder, nut meat, egg powder, polyols, sodium caseinate, mono and di-glycerin fatty acid ester, docosahexaenoic acid, arachidonic acid, taurine, phosphatidylcholine, phosphatidylserine, mineral substances, vitamins and the like, all components are interacted, the food and drink composition can promote metabolism in the body to produce acetoacetic acid, beta-hydroxybutyrate and acetone through dietary intervention to cause a series of biochemical influences on the brain under a condition of meeting primary nutrients requirement for the growth of autistic children, so as to achieve the effect of intervention treatment of infantile autism. The invention also discloses a preparation method and application of the food and drink composition.

An agent capable of decreasing the activity of NKX6.3 for use in (i) reducing fat accumulation and / or (ii) preserving or increasing fat free mass in a subject. A method for predicting the degree of reduction in fat accumulation by applying one or more dietary interventions to a subject and / or predicting the degree of preservation or increase in fat free mass by applying one or more dietary interventions is also provided.

An agent capable of decreasing the activity of NKX6.3 for use in (i) reducing fat accumulation and / or (ii) preserving or increasing fat free mass in a subject. A method for predicting the degree of reduction in fat accumulation by applying one or more dietary interventions to a subject and / or predicting the degree of preservation or increase in fat free mass by applying one or more dietary interventions is also provided.

A method for predicting the degree of weight loss in male subject attainable by applying one or more dietary interventions to a subject, said method comprising determining the level of one or more biomarkers in one or more samples obtained from the subject, wherein the biomarkers are selected from sex hormone-binding globulin, beta-2-microglobulin and serum paraoxonase / arylesterase.

The invention discloses a formula and a preparation method of a litchi-flavored sauce suitable for diabetic patients, and solves the problem that traditional sauces in the prior art satisfy the tasterequirement and neglects the nutritional value, and is not suitable for the long-term consumption of diabetics. The functional sauce of the present invention is prepared from the following raw materials in parts by weight: 150-250 parts of a tomato paste, 150-250 parts of a tomato sauce, 300-450 parts of peeled minced tomatoes, 2-16 parts of stevia, 5-15 parts of low-sodium salt, 45-65 parts of onions, 25-45 parts of ginger, 25-45 parts of garlic, 30-60 parts of inulin, 120-180 parts of pure water, 5-20 parts of aromatic vinegar, 20-40 parts of yellow rice wine, 20-40 parts of corn oil, 20-40parts of peanut oil, 20-40 parts of rapeseed oil, and 20-40 parts of olive oil. The litchi-flavored sauce can realize the auxiliary treatment on diabetes by daily dietary intervention, and assists intreating diabetes while ensuring scientific and reasonable nutrient intake.

A method for predicting the degree of weight loss in a female subject attainable by applying one or more dietary interventions to a subject, said method comprising; determining the level of one or more biomarkers in one or more samples obtained from the subject, wherein the biomarkers are selected from gelsolin, apolipoprotein B-100, plasma kallikrein, protein Z- dependent protease inhibitor and plasma serine protease inhibitor.

The present invention provides a method for assessing the presence or the risk of development of liver disease or chronic hepatitis B in a subject based on OTUs enriched in CHB patients or healthy controls. Also provided is a method for monitoring response to disease treatment or diet intervention in a subject having liver disease or chronic hepatitis B based on these OTUs.

A method for predicting the degree of weight loss in a female subject attainable by applying one or more dietary interventions to a subject, said method comprising; determining the level of one or more biomarkers in one or more samples obtained from the subject, wherein the biomarkers are selected from gelsolin, apolipoprotein B-100, plasma kallikrein, protein Z-dependent protease inhibitor and plasma serine protease inhibitor.

The present invention relates to a method of determining the likelihood that an individual has irritable bowel syndrome and whether an individual will respond to a dietary intervention. The invention also provides a method of determining the likelihood that an individual having irritable bowel syndrome responds to a dietary intervention. Also provided are uses of the compounds as defined herein as biomarkers.

The invention discloses a new use of nucleotide and its use in preparing medicines for preventing and treating diseases such as allergic rhinitis or functional food for alleviating symptoms of allergic rhinitis. Nucleotides are a mixture of five nucleotides: CMP, AMP, UMP, GMP, and IMP. Nucleotides have a small molecular weight, can be absorbed by the human body quickly and have high bioavailability. The present invention finds that the intake of nucleotides can alleviate the symptoms of allergic rhinitis in mice, alleviate the splenomegaly caused by allergy, significantly reduce the level of histamine in serum and nasal lavage fluid, and effectively regulate inflammatory factors, thereby treating allergies effect of disease. It can be used to prepare drugs for preventing and treating allergic rhinitis and other diseases or functional food for alleviating symptoms of allergic rhinitis, and provides a new way for dietary intervention to regulate immune function.

The present invention relates to dietary fiber compositions that can provide an increased level of acetate in the distal colon. Increase levels of acetate (or other short chain fatty acids; SCFA's) in the distal part of the colon is believed to be beneficial in the treatment of various diseases or conditions, such as being overweight or obese. To accomplish this using dietary intervention, which is clearly the preferred (first-line) option for the treatment and / or prevention of obesity (and related disorders), has been a challenge. It was now surprisingly found that combinations of an inulin-type fructan and resistant starch can be orally consumed to substantially increase the level of acetate in the distal part of the colon in human subjects. Hence, the present invention provides dietary fiber products comprising combinations of an inulin-type fructan and resistant starch, alimentary products comprising such dietary fiber compositions, as well as the use of the dietary fiber compositions or the products containing them in the treatment or prevention of a medical or non-medical condition, such as obesity or being overweight.

A method for predicting the degree of weight loss attainable by applying one or more dietary interventions to a subject, said method comprising determining the level of one or more biomarkers in one or more samples obtained from the subject, wherein the biomarkers are selected from fructosamine and factor VII.

The invention discloses a nutritional formula food for type 2 diabetic patients. The nutritional formula food is prepared by the following steps of 1, weighing buckwheat flour, onions, pumpkins, spinach, bitter gourds, cortex cinnamomi, tremella fuciformis, semen coicis, radix angelicae sinensis, rhizoma alismatis, cortex moutan, rhizoma dioscoreae, herba portulacae, radix astragali, rhizoma anemarrhenae, fructus lycii and water. Through cooperative use of an air cylinder, a connecting rod I, a connecting rod III, an extrusion plate, a sieve plate and a filter plate, the yield of effective components is increased, medicine residues are filtered, the tediousness of follow-up filtering operation is reduced, and the working efficiency of a user is improved; the pumpkins contain fructose capable of inhibiting glucose absorption, and the absorption is blocked, so that the effect of reducing blood glucose is achieved; and the food can serve as powder to be taken after being mixed with water,can serve as a dinner, is convenient to store and carry, has a diet intervention effect, and has a remarkable effect of reducing blood glucose.

Biomarkers for predicting weight loss The present invention provides a method for predicting the degree of weight loss attainable by applying one or more dietary interventions to a subject, said method comprising; determining the level of one or more biomarkers in one or more samples obtained from the subject, wherein the one or more biomarkers include vitamin K-dependent protein C.

The invention discloses a method for predicting the weight loss intervention effect of a low-carbon diet by using a neural network model. Obtain the relative abundance and weight loss index of the intestinal flora at the genus level before weight loss of the subject to be evaluated, use the relative abundance data and weight loss index as the parameters of the neural network model, and use the neural network model to predict the weight loss of the low-carb diet intervention effect. Low-carb diet interventions lead to significant weight loss and elevated certain gut flora. Using advanced computational algorithms, such as random forests and artificial neural networks (ANNs), we discovered butyrate-producing bacteria following a low-carb diet intervention. We demonstrate that the relative abundance of Bacteroidetes bacteria is a positive outcome predictor of weight loss in individuals following a low-carbohydrate dietary intervention. Furthermore, using these unique gut microbial structures at baseline, we established a neural network algorithm-based predictive model to assess the weight loss potential of each clinical trial, with the aim of developing effective weight loss strategies.